New Jersey's Medical Insurance: The Oxycodone Crackdown

is nj medical insurance cracking down on oxycodone

Oxycodone is a semi-synthetic opioid medication derived from the opium poppy plant. It is prescribed to relieve moderate to severe pain. Oxycodone is highly addictive, and its misuse has resulted in an opioid crisis that claims the lives of hundreds of Americans daily. In 2017, New Jersey sanctioned 31 doctors for unethical opioid prescription practices, and the state has since launched initiatives to combat the opioid epidemic. This raises the question: Is New Jersey medical insurance cracking down on oxycodone?

Characteristics Values
Is NJ medical insurance cracking down on oxycodone? In 2017, New Jersey Gov. Chris Christie's administration cracked down on the opioid epidemic by sanctioning 31 doctors for opioid prescription abuse.
Oxycodone A semi-synthetic opioid medication derived from the opium poppy plant. It is prescribed in hospitals and outpatient settings to relieve moderate to severe pain.
Oxycodone vs OxyContin Oxycodone provides pain relief for 4-6 hours and can be taken every 6 hours. OxyContin is prescribed in higher doses and provides around-the-clock pain relief.
Oxycodone's Addictiveness Oxycodone and OxyContin are equally addictive, with patients becoming addicted in as little as one week. Between 21-29% of patients prescribed opioids for chronic pain abuse their prescription.
NJ CARES The New Jersey Coordinator for Addiction Responses and Enforcement Strategies, launched in 2018, is fighting the opioid crisis by holding drug companies accountable and developing a network of "Opioid Response Teams."

shunins

Oxycodone's highly addictive nature

Oxycodone is a semi-synthetic opioid medication derived from the opium poppy plant. It is a powerful and potent painkiller, often prescribed to treat moderate to severe pain. While oxycodone can be safe and effective when used as prescribed for short periods of time, it is highly addictive and has a significant risk of abuse and diversion.

Oxycodone is classified as a Schedule II drug under the Controlled Substances Act, which means that while it has a legitimate medical purpose, there is a high potential for abuse. The drug is designed to provide around-the-clock pain relief, but its addictive nature has led to widespread abuse. People can become addicted to oxycodone in as little as one week, and the transition from prescribed use to abuse can be rapid and dangerous.

The addictive qualities of oxycodone have caused controversy and confusion about its role in pain management. Oxycodone triggers a rush of dopamine in the brain, resulting in a euphoric high. While many people use oxycodone to manage pain, some find themselves craving the euphoric effects, leading to abuse and addiction. The drug is often abused by taking higher doses than prescribed, using it for longer than recommended, or ingesting it through chewing, injecting, or snorting.

The abuse of oxycodone can have devastating consequences, including overdose and death. Between 21-29% of patients who are prescribed opioids for chronic pain abuse their prescription, and between 8-12% develop an opioid use disorder. Oxycodone's potency and appeal to drug users and people with opioid use disorders have contributed to its high potential for abuse. Additionally, the social acceptance of prescription painkillers can make it difficult to identify and address oxycodone abuse, especially in cases of legitimate prescriptions.

It is crucial to use oxycodone only under the direct supervision of a doctor, who can monitor dosage and response to the drug, including the potential for misuse and addiction. Recognizing the signs of oxycodone addiction is essential, as it can help save lives and prevent the devastating consequences of abuse.

shunins

Oxycodone's availability in New Jersey

Oxycodone is a semi-synthetic opioid medication derived from the opium poppy plant. It is prescribed in hospitals and outpatient settings to relieve moderate to severe pain. Oxycodone is available as a single-ingredient medication or as a combination medication with acetaminophen or paracetamol. Single-ingredient oxycodone is sold under the brand names Oxaydo and Roxicodone, while the combination medication is marketed as OxyContin, Percocet, or Percodan.

In New Jersey, oxycodone can be obtained through a prescription from a medical professional. It is commonly prescribed for post-surgical operations or the treatment of severe injuries. However, it is essential to recognize the highly addictive nature of oxycodone and the risk for abuse and diversion. Studies show that between 21-29% of patients prescribed opioids for chronic pain abuse their prescription, and 8-12% develop an opioid use disorder.

The state of New Jersey is actively addressing the opioid crisis, which has claimed the lives of numerous Americans. While I cannot confirm if medical insurance is specifically cracking down on oxycodone, it is clear that there is a concerted effort to combat the negative impacts of opioid abuse. This includes prescription opioids like oxycodone, which have been at the center of the crisis due to their addictive nature and deadly consequences when misused.

shunins

Doctors sanctioned for over-prescribing Oxycodone

Doctors have faced sanctions for over-prescribing Oxycodone, a drug that has been at the centre of the opioid crisis. Oxycodone is a semi-synthetic opioid medication derived from the opium poppy plant. It is highly addictive, and between 21-29% of patients prescribed opioids for chronic pain abuse their prescription. Oxycodone is often prescribed to treat severe, acute, and chronic pain, and it can be safe and effective if taken as prescribed for short periods of time. However, it is deadly when abused, and it has been over-prescribed by some doctors.

In the United States, the DEA (Drug Enforcement Administration) has prosecuted operators of pill mills and doctors who prescribed opioids. However, it has also been accused of mounting a witch hunt against conscientious clinicians. The DEA is a federal law enforcement agency that enforces the CSA, a federal criminal drug law prohibiting illegal drug manufacturing and distribution. Under the CSA, drugs are placed into one of five schedules based on their medical utility and potential for abuse and dependence, with most opioids listed as Schedule II drugs.

Some doctors have faced sanctions for failing to follow rules related to opioid prescriptions and putting patients at risk. For example, in Washington state, medical boards sanctioned prescribers for inappropriate prescribing of opioids, and in Louisiana, Dr. Jarrott was disciplined for a pattern of misprescribing opioids and benzodiazepines without adequate documentation or evaluation of the medications' effectiveness. In another case, a physician named Volkman had his certificate of registration and distributor registration revoked and was sued for wrongful death after tripling a patient's oxycodone dose, leading to an overdose.

The over-prescription of opioids by doctors has been blamed for the opioid crisis, but this explanation has been disputed. While opioid prescribing grew steadily from 1980 to 2011, with oxycodone prescriptions increasing during that time, data suggests that there is no cause-and-effect relationship between prescribing rates and opioid-related hospitalization or overdose mortality. Instead, the opioid crisis is driven by both illicit opioids and prescription opioids, with volumes of opioids prescribed by pill mills and "patients" who doctor-shopped also contributing to the problem.

shunins

NJ CARES' role in fighting the opioid crisis

The opioid crisis in the United States continues to claim hundreds of lives daily, with no signs of abating. The crisis is driven by both illicit opioids like heroin and fentanyl, and prescription opioids such as oxycodone, hydrocodone, morphine, and codeine. Oxycodone, in particular, is highly addictive, and its potency makes it appealing to drug users and those with opioid use disorder.

In 2018, the New Jersey Attorney General's Office established the New Jersey Coordinator for Addiction Responses and Enforcement Strategies, or NJ CARES, to combat the opioid epidemic. NJ CARES employs the Attorney General's criminal, civil, and regulatory authority in a coordinated manner to save lives and heal communities affected by opioids.

One of NJ CARES's key initiatives is the development of "Opioid Response Teams," consisting of police officers, recovery coaches, and EMTs, who provide 24/7 assistance to individuals in crisis in the most affected areas of New Jersey. Additionally, NJ CARES has been instrumental in holding drug companies accountable for their role in the opioid crisis. The Attorney General's Office has filed lawsuits against corporations and individuals, including Purdue Pharmaceuticals and members of its founding family.

NJ CARES also focuses on ensuring the safe and appropriate use of prescription opioids. Through the Division of Consumer Affairs, the Attorney General's Office manages New Jersey's Prescription Monitoring Program (PMP), tracking sales of narcotic painkillers and other addictive drugs. This enables the office to swiftly act against doctors and medical professionals who recklessly or intentionally over-prescribe opioids, seeking revocation of their professional licenses.

Furthermore, NJ CARES has partnered with county prosecutors to expand "Operation Helping Hand" statewide. This initiative diverts individuals struggling with substance abuse away from the criminal justice system and into treatment programs, facilitating their recovery. The organization also utilizes data to address the opioid crisis and educate the public. The Integrated Drug Awareness Dashboard, an electronic platform, assists law enforcement and state officials in tracking the latest developments. Anonymized data is also made available to the public through njcares.gov, providing real-time insights into the epidemic's impact.

shunins

Oxycodone's role in the opioid crisis

Oxycodone is a semi-synthetic opioid that is derived from the opium poppy plant. It is prescribed in hospitals and outpatient settings to relieve moderate to severe pain. Oxycodone is highly addictive and has been at the centre of the opioid crisis, which continues to claim the lives of hundreds of Americans daily. The drug is available as a single-ingredient medication or in combination with other drugs such as acetaminophen or paracetamol. Oxycodone is marketed under brand names such as OxyContin, Oxaydo, and Roxicodone.

Oxycodone and OxyContin are equally addictive, and people can become addicted to them within a week. OxyContin is a time-released version of oxycodone, which can be prescribed in higher doses and provides around-the-clock pain relief. Oxycodone, on the other hand, provides pain relief for 4-6 hours and can be taken every 6 hours. While these medications can be safe and effective when used as prescribed for short periods, they are highly addictive and have a high risk of abuse and diversion. Between 21-29% of patients prescribed opioids for chronic pain abuse their prescription, and 8-12% develop an opioid use disorder. The potency of oxycodone makes it highly appealing to drug users and those with opioid use disorders.

The opioid crisis is driven by illicit opioids like heroin and fentanyl, and prescription opioids such as oxycodone, hydrocodone, morphine, and codeine. In 2019, opioids were involved in over 70% of drug overdose deaths. Oxycodone's role in the crisis is significant, with its addictive nature and potential for abuse contributing to the high number of opioid-related deaths and disorders. The improper marketing and handling of oxycodone by the FDA have also been cited as contributing factors to the opioid crisis.

The FDA's approval of Purdue Pharma's new drug application for extended-release oxycodone in 1995 is a notable example of regulatory failure. The drug's label featured a broad indication, allowing Purdue to promote its use for conditions where opioids are more harmful than beneficial, such as low-back pain and fibromyalgia. This broad indication contradicted the guidance of public health agencies, which recommended more cautious prescribing of opioids. The FDA's conduct is particularly concerning given the close relationship between agency officials and opioid manufacturers, with several FDA staff involved in opioid approvals later working for opioid makers.

To address the opioid crisis, the FDA must enforce the Food, Drug, and Cosmetic Act and act on recommendations to overhaul opioid approval and removal policies. Labels on opioid medications should include explicit warnings against long-term use and high-dose prescribing, reinforcing guidance from public health agencies. Oversight bodies within the Executive Branch and Congress should also examine the FDA's role in the opioid crisis to ensure that public health is prioritized over industry interests.

Frequently asked questions

Yes, NJ medical insurance is cracking down on Oxycodone. Oxycodone is a highly addictive opioid that has been at the center of the opioid crisis, leading to hundreds of deaths daily.

Oxycodone is a highly addictive opioid that has been frequently prescribed to treat severe acute and chronic pain. The crackdown is an effort to fight the opioid epidemic and save lives.

The Attorney General's Office has launched NJ CARES, a program that uses criminal, civil, and regulatory authority to combat the opioid crisis. They are also developing a network of "Opioid Response Teams" and holding drug companies accountable through lawsuits.

There are other opioid medications such as hydrocodone, morphine, and codeine that can be prescribed for pain relief. However, it is important to note that these opioids also carry a risk of addiction and abuse. It is always best to consult with a medical professional to discuss alternative pain relief options that may be safer and more appropriate for your specific needs.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment